Lista de obras - Dirkjan Hijnen - Dominio Público Uruguay

'En route' to precision medicine

scientific article published on 01 March 2019

A panel of biomarkers for disease severity in atopic dermatitis

artículo científico publicado en 2015

A woman with hyperpigmentations on the upper legs

artículo científico publicado en 2013

Absence of T-regulatory cell expression and function in atopic dermatitis skin

artículo científico publicado en 2006

Acute arthritis and arthralgia as an adverse drug reaction to dupilumab

scientific article published on 06 September 2019

Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema.

artículo científico publicado en 2017

An approach for the transition from systemic immunosuppressants to dupilumab

scientific article published on 13 September 2020

Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.

artículo científico publicado en 2005

Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery

scientific article published on 01 June 2000

Atopic dermatitis: A tale of two distinct pathomechanisms that make you itch.

artículo científico publicado en 2016

Biomarkers detected in dried blood spots from atopic dermatitis patients strongly correlate with disease severity

scientific article published on 05 August 2019

Biomarkers for atopic dermatitis: a systematic review and meta-analysis

artículo científico

Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid

artículo científico publicado en 2015

CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22.

artículo científico publicado en 2012

COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data

artículo científico publicado en 2020

Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series

artículo científico publicado en 2019

Combinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13.

artículo científico publicado en 2015

Current and Future Biomarkers in Atopic Dermatitis.

artículo científico publicado en 2016

Cyclosporin A reduces CD4(+)CD25(+) regulatory T-cell numbers in patients with atopic dermatitis.

artículo científico publicado en 2009

Cyclosporin A treatment is associated with increased serum immunoglobulin E levels in a subgroup of atopic dermatitis patients

scientific article published on 01 September 2007

Differential expression of genes involved in skin homing, proliferation, and apoptosis in CD4+ T cells of patients with atopic dermatitis.

artículo científico publicado en 2005

EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers

artículo científico publicado en 2020

EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients

scientific article published on 16 August 2017

EASI p-EASI: predicting disease severity in atopic dermatitis patients treated with Cyclosporin A

artículo científico publicado en 2018

Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data

artículo científico publicado en 2019

Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis

artículo científico publicado en 2007

Epicutaneous application of house dust mite induces thymic stromal lymphopoietin in nonlesional skin of patients with atopic dermatitis.

artículo científico publicado en 2013

First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding

artículo científico publicado en 2015

Gene expression in CD4+ T-cells reflects heterogeneity in infant wheezing phenotypes

artículo científico publicado en 2008

High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.

artículo científico publicado en 2010

Immunoglobulin free light chains in adult atopic dermatitis patients do not correlate with disease severity.

artículo científico publicado en 2016

Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries

scientific article published on 01 January 1999

Modulation of lymphocyte function in vivo via inhibition of calcineurin or purine synthesis in patients with atopic dermatitis

artículo científico publicado en 2012

Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis

artículo científico publicado en 2017

Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis

artículo científico publicado en 2016

PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation

artículo científico publicado en 2018

Predicting therapy response to mycophenolic acid using UGT1A9 genotyping: towards personalized medicine in atopic dermatitis

artículo científico publicado en 2016

Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization.

artículo científico publicado en 2009

Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs

artículo científico publicado en 2017

Serum biomarker profiles suggest that atopic dermatitis is a systemic disease

artículo científico publicado en 2018

Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.

artículo científico publicado en 2004

The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies.

artículo científico publicado en 2016

Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severity

artículo científico publicado en 2014

Lista de obras de Dirkjan Hijnen

'En route' to precision medicine

A panel of biomarkers for disease severity in atopic dermatitis

A woman with hyperpigmentations on the upper legs

Absence of T-regulatory cell expression and function in atopic dermatitis skin

Acute arthritis and arthralgia as an adverse drug reaction to dupilumab

Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema.

An approach for the transition from systemic immunosuppressants to dupilumab

Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.

Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery

Atopic dermatitis: A tale of two distinct pathomechanisms that make you itch.

Biomarkers detected in dried blood spots from atopic dermatitis patients strongly correlate with disease severity

Biomarkers for atopic dermatitis: a systematic review and meta-analysis

Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid

CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22.

COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data

Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series

Combinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13.

Current and Future Biomarkers in Atopic Dermatitis.

Cyclosporin A reduces CD4(+)CD25(+) regulatory T-cell numbers in patients with atopic dermatitis.

Cyclosporin A treatment is associated with increased serum immunoglobulin E levels in a subgroup of atopic dermatitis patients

Differential expression of genes involved in skin homing, proliferation, and apoptosis in CD4+ T cells of patients with atopic dermatitis.

EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers

EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients

EASI p-EASI: predicting disease severity in atopic dermatitis patients treated with Cyclosporin A

Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data

Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis

Epicutaneous application of house dust mite induces thymic stromal lymphopoietin in nonlesional skin of patients with atopic dermatitis.

First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding

Gene expression in CD4+ T-cells reflects heterogeneity in infant wheezing phenotypes

High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.

Immunoglobulin free light chains in adult atopic dermatitis patients do not correlate with disease severity.

Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries

Modulation of lymphocyte function in vivo via inhibition of calcineurin or purine synthesis in patients with atopic dermatitis

Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis

Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis

PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation

Predicting therapy response to mycophenolic acid using UGT1A9 genotyping: towards personalized medicine in atopic dermatitis

Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization.

Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs

Serum biomarker profiles suggest that atopic dermatitis is a systemic disease

Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.

The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies.

Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severity